Marty Makary

Blue neon play button icon on dark background

Biotech

FDA plans to release more CRLs as controversial policy resumes

After 14 new rejection letters were published last week following a three-month pause, the FDA today confirmed that the policy has resumed.

Darren Incorvaia Jul 14, 2026 2:50pm

arrow back backwards u-turn turn around reverse

FDA releases 14 drug rejection letters after 3-month pause

Jul 13, 2026 11:01am

pause halt pause button

FDA halts release of new drug rejection letters

Jul 8, 2026 1:33pm

Moderna

FDA appears less prickly toward Moderna mRNA flu shot

Jun 16, 2026 2:46pm

Martin Makary FDA Senate HELP confirmation

Makary FDA reforms ‘continue to move forward’ despite turmoil

May 26, 2026 10:27am

Open door symbolizing exit

Fierce Pharma

CDER chief Høeg and CBER's Szarama exiting FDA posts

May 15, 2026 1:44pm